Insider / DNP SELECT INCOME FUND INC
MetLife Investment Management, LLC
Insider at DNP SELECT INCOME FUND INC
- Company
- DNP SELECT INCOME FUND INC
- First filing on record
- September 20, 2023
- Latest trade on record
- July 22, 2026
- SEC filings
- EDGAR ↗
MetLife Investment Management, LLC, Insider at DNP SELECT INCOME FUND INC, has disclosed 17 transactions in DNP, TYG, NHS since September 20, 2023: 2 purchases (2 open-market buys) and 0 sales, worth about $17.1M at the reported prices. The latest was filed July 24, 2026, 2 days after the trade.
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
In the last 12 months MetLife Investment Management, LLC reported 5 transactions that were neither a purchase nor a sale, such as stock awards, option exercises or shares withheld for tax.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
MetLife Investment Management, LLC has traded 1 stock on record; the largest by dollars is DNP.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
0 of 5 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| J | Other acquisition or disposal | 15 | 138,633,333 | — |
| P | Open-market purchase | 2 | 17,100,000 | $17.1M |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 5 | 0 | 0 |
| 2024 | 5 | 2 · $17.1M | 0 |
| 2023 | 7 | 0 | 0 |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| DNP | Other J | July 22, 2026 | July 24, 2026 | 2d | 2,300,000 | — | — | indirect | Form 4 ↗ | |
| DNP | Other J | July 22, 2026 | July 24, 2026 | 2d | 3,100,000 | — | — | indirect | Form 4 ↗ | |
| DNP | Other J | July 22, 2026 | July 24, 2026 | 2d | 1,700,000 | — | — | indirect | Form 4 ↗ | |
| DNP | Other J | July 22, 2026 | July 24, 2026 | 2d | 32,400,000 | — | — | indirect | Form 4 ↗ | |
| DNP | Other J | July 22, 2026 | July 24, 2026 | 2d | 40,600,000 | — | — | indirect | Form 4 ↗ | |
| TYG | Other J | December 19, 2024 | December 23, 2024 | 4d | 1,290,667 | — | — | indirect | Form 4 ↗ | |
| TYG | Other J | December 19, 2024 | December 23, 2024 | 4d | 1,613,333 | — | — | indirect | Form 4 ↗ | |
| TYG | Other J | December 19, 2024 | December 23, 2024 | 4d | 3,549,333 | — | — | indirect | Form 4 ↗ | |
| DNP | Buy P | August 14, 2024 | August 16, 2024 | 2d | 14,000,000 | $1 | $14.0M | indirect | Form 4 ↗ | |
| DNP | Buy P | July 22, 2024 | July 24, 2024 | 2d | 3,100,000 | $1 | $3.1M | indirect | Form 4 ↗ | |
| NHS | Other J | September 18, 2023 | September 20, 2023 | 2d | 1,344,000 | — | — | indirect | Form 4 ↗ | |
| NHS | Other J | September 18, 2023 | September 20, 2023 | 2d | 768,000 | — | — | indirect | Form 4 ↗ | |
| NHS | Other J | September 18, 2023 | September 20, 2023 | 2d | 3,968,000 | — | — | indirect | Form 4 ↗ | |
| NHS | Other J | September 18, 2023 | September 20, 2023 | 2d | 26,500,000 | — | — | indirect | Form 4 ↗ | |
| NHS | Other J | September 18, 2023 | September 20, 2023 | 2d | 8,583,032 | — | — | indirect | Form 4 ↗ | |
| NHS | Other J | September 18, 2023 | September 20, 2023 | 2d | 5,726,934 | — | — | indirect | Form 4 ↗ | |
| NHS | Other J | September 18, 2023 | September 20, 2023 | 2d | 5,190,034 | — | — | indirect | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| July 24, 2026 | Form 4 | 0000905148-26-003342 | 5 | published | EDGAR ↗ |
| December 23, 2024 | Form 4 | 0000905148-24-003404 | 3 | published | EDGAR ↗ |
| August 16, 2024 | Form 4 | 0000905148-24-002276 | 1 | published | EDGAR ↗ |
| July 24, 2024 | Form 4 | 0000905148-24-001991 | 1 | published | EDGAR ↗ |
| September 20, 2023 | Form 4 | 0000905148-23-000948 | 7 | published | EDGAR ↗ |
Other insiders at DNP SELECT INCOME FUND INC
- BANK OF AMERICA CORP /DE/ Insider 228 rows
- PRUDENTIAL FINANCIAL INC Insider 14 rows
- Saba Capital Management, L.P. Insider 14 rows
- TANK BRADLEY Insider 12 rows
- Corebridge Financial, Inc. Insider 9 rows
- Kocinski Chris Insider 4 rows
- Lind Joseph Insider 4 rows
- CICCOTELLO CONRAD S Director 3 rows
- McLoughlin Philip R Director 2 rows
- MORRISS GEORGE W Director 2 rows
Everyone on file, with contracts and lobbying under the company's name: DNP SELECT INCOME FUND INC.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 5 | 17 | September 20, 2023 | July 24, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.